Group*** | MS | CIS | GBS | Viral encephalitis | SLE | RA | Healthy controls |
---|
Gender**(female:male)
| 32:28 | 19:19 | 10:18 | 26:25 | 22:14 | 20:15 | 27:32 |
Mean age ± SD*(years)
| 35.9 ± 14.8 | 36.0 ± 18.3 | 36.2 ± 20.0 | 30.0 ± 13.7 | 31.6 ± 10.7 | 36.3 ± 9.8 | 35.7 ± 10.2 |
Apo A-I (g/L)
| 1.392 ± 0.047 | 1.388 ± 0.058 | 1.282 ± 0.071 | 1.151 ± 0.051 | 0.940 ± 0.061 | 1.03 ± 0.061 | 1.179 ± 0.047 |
- MS = multiple sclerosis; SLE = systemic lupus erythematosus; RA = rheumatoid arthritis; CIS = Clinically Isolated Syndrome; GBS = Guillain--Barre Syndrome; apoA-I = apolipoproteinA-I.
- Data are means ± SD.* No significant differences, multivarite ANOVA, P = 0.755(P > 0.05). There was no significant effect of age on serum apoA-I levels in different disease groups. ** Significantly different, multivarite ANOVA. P = 0.04(P < 0.05). There was significant effect of sex on serum apoA-I levels. ***Significantly different, multivarite ANOVA. P < 0.001. There was significant effect of gender on serum apoA-I levels.